Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
URGN compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name
URGN
UroGen Pharma Ltd.
Change
Mkt cap
Revenue
Revenue
IMTX
Immatics N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
URGN
UroGen Pharma Ltd.
vs
IMTX
Immatics N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
URGN
UroGen Pharma Ltd.
Change
32.70
▼
−2.33%
· post 32.70
Mkt cap
$1.6B
Revenue
$72M
Q2 FY26
Revenue
$110M
FY25
IMTX
Immatics N.V.
Change
7.20
▼
−1.57%
· post 7.20
Closed
Oct 30 '26
Mkt cap
$965.3M
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
URGN
UroGen Pharma Ltd.
vs
IMTX
Immatics N.V.
32.70
▼
−2.33%
post 32.70
Price
7.20
▼
−1.57%
post 7.20
$1.6B
Mkt cap
$965.3M
Q2 FY26
$72M
Revenue
—
FY25
$110M
Revenue
—
Change
Change
URGN
32.70
▼
−2.33%
vs
IMTX
7.20
▼
−1.57%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
URGN, solid
IMTX, dashed
Supply-chain overlap
Revenue flow
URGN: latest quarter is a loss; flow not drawable. IMTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only URGN
6
AGEN
Agenus
supplier
TEVA
Teva Pharmaceuticals Industries
supplier
—
Cenexi-Laboratories Thissen
unlisted
supplier
—
IconOVir Bio
unlisted
supplier
2 more · URGN chain
›
Shared
0
No shared counterparties.
Only IMTX
2
BMY
Bristol-Myers Squibb
customer
MRNA
ModernaTX
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR